Covis Pharma

Covis Pharma company information, Employees & Contact Information

Updated May 2026

Quick answer

Covis Pharma is a Pharmaceutical Manufacturing company and founded in 2011. It has approximately 482 employees on record. Contact data was last refreshed in May 2026. Find Covis Pharma's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Related company profiles:

Founded in 2011, Covis Pharma is a private equity backed global specialty pharmaceutical company that markets therapeutic solutions in 50+ countries, for patients with life-threatening conditions and chronic illnesses. Our purpose is to turn untapped potential into global medical therapies that improve our patients' lives. Apollo Global Management, with $455 billion AUM, is the private equity sponsor of Covis Pharma.

Company Details

Employees
482
Founded
-
Address
Grafenauweg 12, Zug,6300,switzerland
Phone
1-888-891-5367
Email
in****@****rma.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Keywords
Manager jobs.
HQ
Zug
Looking for a particular Covis Pharma employee's phone or email?

Covis Pharma Questions

News

Azurity Pharmaceuticals Completes Acquisition of Covis Pharma - PR Newswire

Azurity Pharmaceuticals Completes Acquisition of Covis Pharma PR Newswire

Azurity acquires Covis Pharma from existing investors - Pharmaceutical Technology

Azurity acquires Covis Pharma from existing investors Pharmaceutical Technology

Azurity Pharmaceuticals Completes Covis Pharma Acquisition - Pharmaceutical Executive

Azurity Pharmaceuticals Completes Covis Pharma Acquisition Pharmaceutical Executive

Weil Guides Ad Hoc Group of Lenders in Covis Pharma's Cross Border Restructuring - Weil

Weil Guides Ad Hoc Group of Lenders in Covis Pharma's Cross Border Restructuring Weil

Rajiv De Silva Joins Covis Pharma as Chairman of the Board of Directors - Business Wire

Rajiv De Silva Joins Covis Pharma as Chairman of the Board of Directors Business Wire

Phase 3 Trial Assessing Ciclesonide Inhalation Aerosol for COVID-19 Underway - Medical Professionals Reference

Phase 3 Trial Assessing Ciclesonide Inhalation Aerosol for COVID-19 Underway Medical Professionals Reference

Covis Group Announces Agreement to Acquire AMAG Pharmaceuticals - GlobeNewswire

Covis Group Announces Agreement to Acquire AMAG Pharmaceuticals GlobeNewswire

AstraZeneca to transfer some drug rights to Covis Pharma in $270 mln deal - Reuters

AstraZeneca to transfer some drug rights to Covis Pharma in $270 mln deal Reuters

FDA officially withdraws approval of Makena - Contemporary OB/GYN

FDA officially withdraws approval of Makena Contemporary OB/GYN

New Dosage Strengths of Lanoxin Launched - Medical Professionals Reference

New Dosage Strengths of Lanoxin Launched Medical Professionals Reference

Top Covis Pharma Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant